Enhabit, Inc. (NYSE:EHAB) Given Average Rating of “Reduce” by Brokerages

Shares of Enhabit, Inc. (NYSE:EHABGet Free Report) have been assigned an average rating of “Reduce” from the seven research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and six have issued a hold recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $9.25.

Separately, Leerink Partners restated a “market perform” rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a report on Tuesday, November 19th.

Read Our Latest Stock Analysis on Enhabit

Institutional Investors Weigh In On Enhabit

Institutional investors have recently added to or reduced their stakes in the stock. DekaBank Deutsche Girozentrale lifted its position in shares of Enhabit by 39.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 340,412 shares of the company’s stock valued at $3,861,000 after buying an additional 95,488 shares during the last quarter. WINTON GROUP Ltd purchased a new stake in Enhabit during the second quarter valued at approximately $955,000. Marshall Wace LLP acquired a new stake in Enhabit in the second quarter valued at approximately $1,941,000. Orion Portfolio Solutions LLC grew its holdings in Enhabit by 72.5% in the first quarter. Orion Portfolio Solutions LLC now owns 96,833 shares of the company’s stock worth $1,128,000 after purchasing an additional 40,684 shares during the last quarter. Finally, AREX Capital Management LP increased its position in shares of Enhabit by 2.5% during the second quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock worth $22,056,000 after purchasing an additional 59,353 shares in the last quarter.

Enhabit Stock Performance

Shares of NYSE:EHAB opened at $7.56 on Tuesday. The firm’s 50 day simple moving average is $7.50 and its 200-day simple moving average is $8.40. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit has a one year low of $6.85 and a one year high of $11.74. The firm has a market cap of $380.12 million, a PE ratio of -3.26 and a beta of 1.84.

Enhabit (NYSE:EHABGet Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The firm had revenue of $253.60 million for the quarter, compared to analysts’ expectations of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same quarter in the previous year, the business earned $0.03 earnings per share. As a group, equities analysts predict that Enhabit will post 0.22 EPS for the current year.

Enhabit Company Profile

(Get Free Report

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Featured Stories

Analyst Recommendations for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.